Alzheimer's disease
- Australian Imaging, Biomarker and Lifestyle (AIBL) Study of Ageing
- Largest study of its kind – 1,110 volunteers
- Long term prospective study of cognition, imaging, biomarkers and lifestyle in Alzheimer’s disease
- Cohort has AD, MCI and healthy controls (ApoE4+, ApoE4- and memory complainers)
- Focus on early detection towards lifestyle interventions
- Multi-disciplinary, 60% in Melbourne, 40% in Perth
- Expressions of interest welcomed from commercial and academic groups
- Confidentiality of data generated maintained
